Experience
BioDelivery Sciences International, Inc. et al.
Alvogen PB Research & Development LLC et al.
Represented Finnegan client BioDelivery Sciences International (BDSI), prevailing at trial in a case brought against Alvogen PB Research & Development involving BDSI's highly successful Belbuca© buprenorphine buccal film product, with sales of over $100 million per year.
BioDelivery Sciences International, Inc. et al. v. Alvogen PB Research & Development LLC et al., 1:18-cv-01395, D. Del., Judge Connolly
BioDelivery Sciences International, Inc. et al. v. Chemo Research, SL et al.
BioDelivery Sciences International, Inc. et al.
Grünenthal GmbH et al. v. Alvogen Pine Brook, Inc. et al.
Grünenthal GmbH et al.
Pioneer Hi-Bred International, Inc. et al. v. Syngenta Seeds, LLC
Pioneer Hi-Bred International, Inc. et al.
AbbVie Inc.
Regenxbio, Inc. et al. v. Sarepta Therapeutics, Inc. et al.
Sarepta Therapeutics, Inc. et al.
Duchesnay Inc. v. Actavis Laboratories FL, Inc. et al.
Duchesnay Inc.
Novartis Pharmaceuticals Corporation et al. v. Fresenius Kabi USA, LLC et al.
Novartis Pharmaceuticals Corporation et al.
Bell Northern Research, LLC v. HMD America, Inc. et al.
HMD America, Inc. et al.
CMC Materials, LLC v. Dupont de Nemours, Inc. et al.
Dupont de Nemours, Inc. et al.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.